Blood concentrations of synthetic cathinones

References

• European Monitoring Centre for Drugs and Drug Addiction and Europol. EU Drug Markets Report 2019. Publications Office of the European Union, Luxembourg, 2019. Available from: http://www.emcdda.europa.eu/system/files/publications/12078/20192630_TD0319332ENN_PDF.pdf.
   Google Scholar
• Capriola M. Synthetic cathinone abuse. Clin Pharmacol. 2013;5:109–115.
   PubMedGoogle Scholar
• Adamowicz P, Gieroń J, Gil D, et al. The prevalence of new psychoactive substances in biological material - a three-year review of casework in Poland. Drug Test Anal. 2016;8(1):63–70.
   PubMed Web of Science ®Google Scholar
• Maas A, Sydow K, Madea B, et al. Separation of ortho, meta and para isomers of methylmethcathinone (MMC) and methylethcathinone (MEC) using LC-ESI-MS/MS: application to forensic serum samples. J Chromatogr B Analyt Technol Biomed Life Sci. 2017;1051:118–125.
   PubMed Web of Science ®Google Scholar
• Rouxinol D, Carmo H, Carvalho F, et al. Pharmacokinetics, pharmacodynamics, and toxicity of the new psychoactive substance 3,4-dimethylmethcathinone (3,4-DMMC). Forensic Toxicol. 2020;38(1):15–29.
   Web of Science ®Google Scholar
• Usui K, Aramaki T, Hashiyada M, et al. Quantitative analysis of 3,4-dimethylmethcathinone in blood and urine by liquid chromatography-tandem mass spectrometry in a fatal case. Leg Med (Tokyo). 2014;16(4):222–226.
   PubMed Web of Science ®Google Scholar
• Kubo SI, Waters B, Hara K, et al. A report of novel psychoactive substances in forensic autopsy cases and a review of fatal cases in the literature. Leg Med (Tokyo). 2017;26:79–85.
   PubMed Web of Science ®Google Scholar
• Tóth A, Kovács K, Árok Z, et al. The role of stimulant designer drug consumption in three fatal cases in South-East Hungary in 2011. RJML. 2013;21(4):275–280.
   Web of Science ®Google Scholar
• Sykutera M, Bloch-Bogusławska E. A fatal case of 3,4-dimethylmethcathinone poisoning. Probl For Sci. 2015;102:138–148.
   Google Scholar
• Zaami S, Giorgetti R, Pichini S, et al. Synthetic cathinones related fatalities: an update. Eur Rev Med Pharmacol Sci. 2018;22(1):268–274.
   PubMed Web of Science ®Google Scholar
• Kulikowska J, Korczyńska M, Pieprzyca E, et al. Ostre zatrucie 3,4-DMMC ze skutkiem śmiertelnym. XXXI Konferencja Toksykologów Sądowych, Ciechocinek, 7–9 maja 2014 r.
   Google Scholar
• Elliott S, Evans J. A 3-year review of new psychoactive substances in casework. Forensic Sci Int. 2014;243:55–60.
   PubMed Web of Science ®Google Scholar
• Murray B, Murphy C, Beuhler M. Death following recreational use of designer drug “bath salts” containing 3,4-methylenedioxypyrovalerone (MDPV). J Med Toxicol. 2012;8(1):69–75.
   PubMedGoogle Scholar
• Namera A, Urabe S, Saito T, et al. A fatal case of 3,4-methylenedioxypyrovalerone poisoning: coexistence of α-pyrrolidinobutiophenone and α-pyrrolidinovalerophenone in blood and/or hair. Forensic Toxicol. 2013;31(2):338–343.
   Web of Science ®Google Scholar
• Adamowicz P, Gil D, Skulska A, et al. Analysis of MDPV in blood-determination and interpretation. J Anal Toxicol. 2013;37(5):308–312.
   PubMed Web of Science ®Google Scholar
• Kesha K, Boggs CL, Ripple MG, et al. Methylenedioxypyrovalerone ("bath salts"), related death: case report and review of the literature. J Forensic Sci. 2013;58(6):1654–1659.
   PubMed Web of Science ®Google Scholar
• Wyman JF, Lavins ES, Engelhart D, et al. Postmortem tissue distribution of MDPV following lethal intoxication by "bath salts". J Anal Toxicol. 2013;37(3):182–185.
   PubMed Web of Science ®Google Scholar
• Liveri K, Constantinou MA, Afxentiou M, et al. A fatal intoxication related to MDPV and pentedrone combined with antipsychotic and antidepressant substances in Cyprus. Forensic Sci Int. 2016;265:160–165.
   PubMed Web of Science ®Google Scholar
• Lehmann S, Schulze B, Thomas A, et al. Organ distribution of 4-MEC, MDPV, methoxetamine and α-PVP: comparison of QuEChERS and SPE. Forensic Toxicol. 2018;36(2):320–333.
   Web of Science ®Google Scholar
• Chung H, Lee J, Kim E. Trends of novel psychoactive substances (NPSs) and their fatal cases. Forensic Toxicol. 2016;34(1):1–11.
   Web of Science ®Google Scholar
• Paillet-Loilier M, Cesbron A, Le Boisselier R, et al. Emerging drugs of abuse: current perspectives on substituted cathinones. Subst Abuse Rehabil. 2014;5:37–52.
   PubMedGoogle Scholar
• Kriikku P, Wilhelm L, Schwarz O, et al. New designer drug of abuse: 3,4-Methylenedioxypyrovalerone (MDPV). Findings from apprehended drivers in Finland. Forensic Sci Int. 2011;210(1-3):195–200.
   PubMed Web of Science ®Google Scholar
• Kriikku P, Wilhelm L, Schwarz O, et al. Methylenedioxypyrovalerone (MDPV) in Finland. Toxichem Krimtech. 2011;78:293–296.
   Google Scholar
• Baselt R. Disposition of toxic drugs and chemicals in man, Baselt, 11th edn. Seal Beach, California: Biomedical Publications; 2017.
   Google Scholar
• Richards-Waugh LL, Bailey KM, Gebhardt MA, et al. Bizarre behavior and death following ingestion of MDPV (“bath salts”). Presented at the annual meeting of the International Association of Forensic Toxicologists, San Francisco, CA, September 29, 2011.
   Google Scholar
• Spiller HA, Ryan ML, Weston RG, et al. Clinical experience with and analytical confirmation of "bath salts" and "legal highs" (synthetic cathinones) in the United States. Clin Toxicol (Phila). 2011;49(6):499–505.
   PubMed Web of Science ®Google Scholar
• Spencer JW, Long C, Scalzo AJ, et al. Acute psychiatric, cardiopulmonary, and neurologic effects of laboratory-confirmed use of methylenedioxypyrovalerone (MDPV) “bath salts”. Clin Toxicol (Phila). 2011;49(6):526–527.
   Web of Science ®Google Scholar
• Thornton SL, Gerona RR, Tomaszewski CA. Psychosis from a bath salt product containing flephedrone and MDPV with serum, urine, and product quantification. J Med Toxicol. 2012;8(3):310–313.
   PubMedGoogle Scholar
• Alexy EM, Labay LM, Corvo J. Bioanalytical quantification of MDPV: A paranoia inducing designer stimulant. Presented at the annual meeting of the International Association of Forensic Toxicologists, San Francisco, California, September 29, 2011.
   Google Scholar
• Zuba D, Adamowicz P, Byrska B. Detection of buphedrone in biological and non-biological material-two case reports. Forensic Sci Int. 2013;227(1-3):15–20.
   PubMed Web of Science ®Google Scholar
• Marinetti LJ, Antonides HM. Analysis of synthetic cathinones commonly found in bath salts in human performance and postmortem toxicology: method development, drug distribution and interpretation of results. J Anal Toxicol. 2013;37(3):135–146.
   PubMed Web of Science ®Google Scholar
• Young AC, Schwarz ES, Velez LI, et al. Two cases of disseminated intravascular coagulation due to "bath salts" resulting in fatalities, with laboratory confirmation. Am J Emerg Med. 2013;31(2):445.e3–445.e5.
   Web of Science ®Google Scholar
• Diestelmann M, Zangl A, Herrle I, et al. MDPV in forensic routine cases: psychotic and aggressive behavior in relation to plasma concentrations. Forensic Sci Int. 2018;283:72–84.
   PubMed Web of Science ®Google Scholar
• Beck O, Franzen L, Bäckberg M, et al. Intoxications involving MDPV in Sweden during 2010-2014: results from the STRIDA project. Clin Toxicol (Phila). 2015;53(9):865–873.
   PubMed Web of Science ®Google Scholar
• Maas A, Wippich C, Madea B, et al. Driving under the influence of synthetic phenethylamines: a case series. Int J Legal Med. 2015;129(5):997–1003.
   PubMed Web of Science ®Google Scholar
• Froberg BA, Levine M, Beuhler MC, et al. Acute methylenedioxypyrovalerone toxicity. J Med Toxicol. 2015;11(2):185–194.
   PubMed Web of Science ®Google Scholar
• Desharnais B, Dazé Y, Huppertz LM, et al. A case of fatal idiosyncratic reaction to the designer drug 3,4-methylenedioxypyrovalerone (MDPV) and review of the literature. Forensic Sci Med Pathol. 2017;13(3):350–354.
   PubMed Web of Science ®Google Scholar
• Grapp M, Kaufmann C, Ebbecke M. Toxicological investigation of forensic cases related to the designer drug 3,4-methylenedioxypyrovalerone (MDPV): detection, quantification and studies on human metabolism by GC-MS. Forensic Sci Int. 2017;273:1–9.
   PubMed Web of Science ®Google Scholar
• Wright TH, Cline-Parhamovich K, Lajoie D, et al. Deaths involving methylenedioxypyrovalerone (MDPV) in Upper East Tennessee. J Forensic Sci. 2013;58(6):1558–1562.
   PubMed Web of Science ®Google Scholar
• Kriikku P, Rintatalo J, Pihlainen K, et al. The effect of banning MDPV on the incidence of MDPV-positive findings among users of illegal drugs and on court decisions in traffic cases in Finland. Int J Legal Med. 2015;129(4):741–749.
   PubMed Web of Science ®Google Scholar
• Cawrse BM, Levine B, Jufer RA, et al. Distribution of methylone in four postmortem cases. J Anal Toxicol. 2012;36(6):434–439.
   PubMed Web of Science ®Google Scholar
• Zawilska JB, Wojcieszak J. α-Pyrrolidinophenones: a new wave of designer cathinones. Forensic Toxicol. 2017;35(2):201–216.
   Web of Science ®Google Scholar
• Yap S, Drummer OH. Prevalence of new psychoactive substances in Victorian fatally-injured drivers. Aust J Forensic Sci. 2016;48(2):230–243.
   Web of Science ®Google Scholar
• Glicksberg L, Winecker R, Miller C, et al. Postmortem distribution and redistribution of synthetic cathinones. Forensic Toxicol. 2018;36(2):291–303.
   Web of Science ®Google Scholar
• Katselou M, Papoutsis I, Nikolaou P, et al. α-PVP (“flakka”): a new synthetic cathinone invades the drug arena. Forensic Toxicol. 2016;34(1):41–50.
   Web of Science ®Google Scholar
• Namera A, Kawamura M, Nakamoto A, et al. Comprehensive review of the detection methods for synthetic cannabinoids and cathinones. Forensic Toxicol. 2015;33(2):175–194.
   PubMed Web of Science ®Google Scholar
• deRoux SJ, Dunn WA. "Bath Salts" the New York City Medical Examiner Experience: a 3-year retrospective review. J Forensic Sci. 2017;62(3):695–699.
   PubMed Web of Science ®Google Scholar
• Kronstrand R, Guerrieri D, Vikingsson S, et al. Fatal poisonings associated with new psychoactive substances. Handb Exp Pharmacol. 2018;252:495–541.
   PubMedGoogle Scholar
• Adamowicz P, Gieroń J, Gil D, et al. Blood concentrations of α-pyrrolidinovalerophenone (α-PVP) determined in 66 forensic samples. Forensic Toxicol. 2016;34(2):227–234.
   Web of Science ®Google Scholar
• Wiergowski M, Woźniak MK, Kata M, et al. Determination of MDPBP in postmortem blood samples by gas chromatography coupled with mass spectrometry. Monatsh Chem. 2016;147:1415–1421.
   PubMed Web of Science ®Google Scholar
• Byard RW, Cox M, Stockham P. Blunt craniofacial trauma as a manifestation of excited delirium caused by new psychoactive substances. J Forensic Sci. 2016;61(6):1546–1548.
   PubMed Web of Science ®Google Scholar
• Beck O, Bäckberg M, Signell P, et al. Intoxications in the STRIDA project involving a panorama of psychostimulant pyrovalerone derivatives, MDPV copycats. Clin Toxicol (Phila). 2018;56(4):256–263.
   PubMed Web of Science ®Google Scholar
• Woźniak MK, Banaszkiewicz L, Wiergowski M, et al. Development and validation of a GC–MS/MS method for the determination of 11 amphetamines and 34 synthetic cathinones in whole blood. Forensic Toxicol. 2020;38(1):42–58.
   Web of Science ®Google Scholar
• Adamowicz P, Hydzik P. Fetal death associated with the use of 3,4-MDPHP and α-PHP. Clin Toxicol (Phila). 2019;57(2):112–116.
   PubMed Web of Science ®Google Scholar
• Vogt S, Grumann C, Thierauf-Emberger A, et al. P22 Death by MDPHP. Proceedings of the XX. GTFCh-Symposium. Toxichem Krimtech. 2017;84(2):102.
   Google Scholar
• Thornton SL, Lo J, Clark RF, et al. Simultaneous detection of multiple designer drugs in serum, urine, and CSF in a patient with prolonged psychosis. Clin Toxicol (Phila). 2012;50(10):1165–1168.
   PubMed Web of Science ®Google Scholar
• Adamowicz P, Zuba D, Byrska B. Fatal intoxication with 3-methyl-N-methylcathinone (3-MMC) and 5-(2-aminopropyl)benzofuran (5-APB). Forensic Sci Int. 2014;245:126–132.
   PubMed Web of Science ®Google Scholar
• Adamowicz P, Gieroń J, Gil D, et al. 3-methylmethcathinone-interpretation of blood concentrations based on analysis of 95 cases. J Anal Toxicol. 2016;40(4):272–276.
   PubMed Web of Science ®Google Scholar
• Karinen R, Tuv SS, Rogde S, et al. Lethal poisonings with AH-7921 in combination with other substances. Forensic Sci Int. 2014;244:e21–e24.
   PubMed Web of Science ®Google Scholar
• Ferreira B, Dias da Silva D, Carvalho F, et al. The novel psychoactive substance 3-methylmethcathinone (3-MMC or metaphedrone): a review. Forensic Sci Int. 2019;295:54–63.
   PubMed Web of Science ®Google Scholar
• Bäckberg M, Lindeman E, Beck O, et al. Characteristics of analytically confirmed 3-MMC-related intoxications from the Swedish STRIDA project. Clin Toxicol (Phila). 2015;53(1):46–53.
   PubMed Web of Science ®Google Scholar
• Jamey C, Kintz P, Martrille L, et al. Fatal combination with 3-methylmethcathinone (3-MMC) and gamma-hydroxybutyric acid (GHB). J Anal Toxicol. 2016;40(7):546–552.
   PubMed Web of Science ®Google Scholar
• Rojek S, Kula K, Maciow-Glab M, et al. Determination of 3-MMC and identification of its metabolites by GC-EI-MS-MS and GC-EI/PCI-MS in postmortembiological material. 53rd TIAFT meeting, Firenze, Italy, 2015.
   Google Scholar
• Bottinelli C, Cartiser N, Gaillard Y, et al. A fatal case of 3-methylmethcathinone (3-MMC) poisoning. Toxicol Anal Clin. 2017;29(1):123–129.
   Web of Science ®Google Scholar
• Margasińska-Olejak J, Celiński R, Fischer A, et al. A fatal case of poisoning of a 19-year-old after taking 3-MMC. Forensic Sci Int. 2019;300:e34–e37.
   PubMed Web of Science ®Google Scholar
• Ameline A, Dumestre-Toulet V, Raul JS, et al. Determination of a threshold fatal 3-MMC concentration in human: mission impossible. Psychopharmacology (Berl). 2019;236(3):865–867.
   PubMed Web of Science ®Google Scholar
• Institóris L, Hidvégi E, Dobos A, et al. The role of illicit, licit, and designer drugs in the traffic in Hungary. Forensic Sci Int. 2017;275:234–241.
   PubMed Web of Science ®Google Scholar
• Wagmann L, Manier SK, Eckstein N, et al. Toxicokinetic studies of the four new psychoactive substances 4-chloroethcathinone, N-ethylnorpentylone, N-ethylhexedrone, and 4-fluoro-alpha-pyrrolidinohexiophenone. Forensic Toxicol. 2020;38(1):59–69.
   Web of Science ®Google Scholar
• Kudo K, Usumoto Y, Kikura-Hanajiri R, et al. A fatal case of poisoning related to new cathinone designer drugs, 4-methoxy PV8, PV9, and 4-methoxy PV9, and a dissociative agent, diphenidine. Leg Med (Tokyo)). 2015;17(5):421–426.
   PubMed Web of Science ®Google Scholar
• Yonemitsu K, Sasao A, Mishima S, et al. A fatal poisoning case by intravenous injection of "bath salts" containing acetyl fentanyl and 4-methoxy PV8. Forensic Sci Int. 2016;267:e6–e9.
   PubMed Web of Science ®Google Scholar
• Katselou M, Papoutsis I, Nikolaou P, et al. Diphenidine: a dissociative NPS makes an entrance on the drug scene. Forensic Toxicol. 2018;36(2):233–242.
   Web of Science ®Google Scholar
• Shintani-Ishida K, Nakamura M, Tojo M, et al. Identification and quantification of 4-methyl–pyrrolidinobutiophenone (4-MeOPBP) in human plasma and urine using LC-TOF-MS in an autopsy case. Forensic Toxicol. 2015;33(2):348–354.
   Web of Science ®Google Scholar
• Bottinelli C, Bevalot F, Boucher A, et al. P48: Death by 4-methylethcathinone (4-MEC) overdose: a case report. Toxicol Anal Clin. 2014;26(2):50.
   Google Scholar
• Gil D, Adamowicz P, Skulska A, et al. Analysis of 4-MEC in biological and non-biological material-three case reports. Forensic Sci Int. 2013;228(1-3):e11–e15.
   PubMed Web of Science ®Google Scholar
• Rojek S, Kłys M, Maciów M, et al. Two fatal cases of intoxication with 4-MMC and 4-MEC – medicolegal expertise. Annual Meeting of the International Association of Forensic Toxicologists, 4 June 2012. Hamamatsu, Japan, 2012.
   Google Scholar
• Smith PR, Cole R, Hamilton S, et al. Reporting two fatalities associated with the use of 4-methylethcathinone (4-MEC) and a review of the literature. J Anal Toxicol. 2016;40(7):553–560.
   PubMed Web of Science ®Google Scholar
• Pellegrini M, Bolino G, Varì MR, et al. A fatal chemsex case involving γ-butyrolactone and 4-methylethcathinone. Drug Test Anal. 2019;11(9):1465–1470.
   PubMed Web of Science ®Google Scholar
• Rojek S, Kłys M, Maciów-Głąb M, et al. Cathinones derivatives-related deaths as exemplified by two fatal cases involving methcathinone with 4-methylmethcathinone and 4-methylethcathinone. Drug Test Anal. 2014;6(7-8):770–777.
   PubMed Web of Science ®Google Scholar
• Turcant A, Boels D, Helfer AG, et al. Acute combined poisoning with the new designer drug 4-methyl-N-ethyl-cathinone (4-MEC) and gammabutyrolactone (GBL): A case report with different analytical approaches for identification of some metabolites. Toxicol Anal Clin. 2014;26(3):119–127.
   Google Scholar
• Knapp A, Humbert L, Etting I, et al. Identification et dosage de la 4-MEC (4-méthyléthylcathinone) et de la MDPV (3,4-méthylènedioxypyrovalérone) dans différents milieux: à propos d’un cas. Ann Toxicol Anal. 2013;25:C41.
   Google Scholar
• Benedicte L, Camille R, Audrey C, et al. Case report on two-cathinones abuse: MPHP and N-ethyl-4′methylnorpentedrone, with a fatal outcome. Forensic Toxicol. 2020;38(1):243–254.
   Web of Science ®Google Scholar
• Lelièvre B, Richeval C, Coulon A, et al. Case report of a drug-related death following the use of cathinone derivatives (MPHP and 4-MEAP). Toxicol Anal Clin. 2019;31(2):S43.
   Google Scholar
• Shintani-Ishida K, Kakiuchi Y, Ikegaya H. Successful quantification of 4'-methyl-α-pyrrolidinohexanophenone (MPHP) in human urine using LC-TOF-MS in an autopsy case. Forensic Toxicol. 2016;34:398–402.
   PubMed Web of Science ®Google Scholar
• Sauer C, Hoffmann K, Schimmel U, et al. Acute poisoning involving the pyrrolidinophenone-type designer drug 4'-methyl-alpha-pyrrolidinohexanophenone (MPHP). Forensic Sci Int. 2011;208(1-3):e20–e25.
   PubMed Web of Science ®Google Scholar
• Fujita Y, Koeda A, Fujino Y, et al. Clinical and toxicological findings of acute intoxication with synthetic cannabinoids and cathinones. Acute Med Surg. 2016;3(3):230–236.
   PubMed Web of Science ®Google Scholar
• Krotulski AJ, Papsun DM, De Martinis BS, et al. N-ethyl pentylone (ephylone) intoxications: quantitative confirmation and metabolite identification in authentic human biological specimens. J Anal Toxicol. 2018;42(7):467–475.
   PubMed Web of Science ®Google Scholar
• Pinorini-Godly MT, Sporket F, Schlapfer M, et al. Intoxication with butylone and phenazepam among youngcocaine users. Toxichem. Krimtech. 2010;77:226–227.
   Google Scholar
• Rojek S, Kłys M, Strona M, et al. "Legal highs"-toxicity in the clinical and medico-legal aspect as exemplified by suicide with bk-MBDB administration . Forensic Sci Int. 2012;222(1-3):e1–e6.
   PubMed Web of Science ®Google Scholar
• Krotulski AJ, Mohr ALA, Papsun DM, et al. Dibutylone (bk-DMBDB): intoxications, quantitative confirmations and metabolism in authentic biological specimens. J Anal Toxicol. 2018;42(7):437–445.
   PubMed Web of Science ®Google Scholar
• Zawadzki M, Nowak K, Szpot P. Fatal intoxication with N-ethylpentylone: a case report and method for determining N-ethylpentylone in biological material. Forensic Toxicol. 2020;38(1):255–263.
   Web of Science ®Google Scholar
• Tomczak E, Woźniak MK, Kata M, et al. Blood concentrations of a new psychoactive substance 4-chloromethcathinone (4-CMC) determined in 15 forensic cases. Forensic Toxicol. 2018;36(2):476–485.
   PubMed Web of Science ®Google Scholar
• Wiergowski M, Aszyk J, Kaliszan M, et al. Identification of novel psychoactive substances 25B-NBOMe and 4-CMC in biological material using HPLC-Q-TOF-MS and their quantification in blood using UPLC-MS/MS in case of severe intoxications. J Chromatogr B Analyt Technol Biomed Life Sci. 2017;1041-1042:1–10.
   PubMed Web of Science ®Google Scholar
• Nowak K, Szpot P, Zawadzki M. Unstability of 4-CMC in human serum specimen. Forensic Toxicol. 2019;37(1):261–264.
   PubMed Web of Science ®Google Scholar
• Mohr ALA, Friscia M, Logan BK. Identification and prevalence determination of novel recreational drugs and discovery of their metabolites in blood, urine, and oral fluid. Award Number: 2013-DN-BX-K018, Document No.: 250338, October 2016, US Dept of Justice NIJ Pub, Washington. https://www.ncjrs.gov/pdffiles1/nij/grants/250338.pdf.
   Google Scholar
• Atherton D, Dye D, Robinson CA, et al. N-ethyl pentylone-related deaths in Alabama. J Forensic Sci. 2019;64(1):304–308.
   PubMed Web of Science ®Google Scholar
• Costa JL, Cunha KF, Lanaro R, et al. Analytical quantification, intoxication case series, and pharmacological mechanism of action for N-ethylnorpentylone (N-ethylpentylone or ephylone). Drug Test Anal. 2019;11(3):461–471.
   PubMed Web of Science ®Google Scholar
• Thirakul P, Hair LS, Bergen KL, et al. Clinical presentation, autopsy results and toxicology findings in an acute N-ethylpentylone fatality. J Anal Toxicol. 2017;41(4):342–346.
   PubMed Web of Science ®Google Scholar
• WHO. Critical Review Report: N-Ethylnorpentylone. Expert Committee on Drug Dependence. Forty-first Meeting, Geneva, 12-16 November 2018.
   Google Scholar
• Lee D, Chronister CW, Hoyer J, et al. Ethylone-related deaths: toxicological findings. J Anal Toxicol. 2015;39(7):567–571.
   PubMed Web of Science ®Google Scholar
• McIntyre IM, Hamm CE, Sherrard JL, et al. Acute 3,4-methylenedioxy-N-ethylcathinone (ethylone) intoxication and related fatality: a case report with post-mortem concentrations. J Anal Toxicol. 2015;39(3):225–228.
   PubMed Web of Science ®Google Scholar
• WHO. Ethylone Critical Review. Expert Committee on Drug Dependence. Thirty-eighth Meeting Geneva, 14–18 November 2016.
   Google Scholar
• Torrance H, Cooper G. The detection of mephedrone (4-methylmethcathinone) in 4 fatalities in Scotland. Forensic Sci Int. 2010;202(1-3):e62–e63.
   PubMed Web of Science ®Google Scholar
• Lusthof K, Oosting R, Maes A, et al. A case of extreme agitation and death after the use of mephedrone in The Netherlands. Forensic Sci Int. 2011;206(1-3):e93–e95.
   PubMed Web of Science ®Google Scholar
• Adamowicz P, Tokarczyk B, Stanaszek R, et al. Fatal mephedrone intoxication-a case report. J Anal Toxicol. 2013;37(1):37–42.
   PubMed Web of Science ®Google Scholar
• Gerace E, Petrarulo M, Bison F, et al. Toxicological findings in a fatal multidrug intoxication involving mephedrone. Forensic Sci Int. 2014;243:68–73.
   PubMed Web of Science ®Google Scholar
• Vaiano F, Busardò FP, Palumbo D, et al. A novel screening method for 64 new psychoactive substances and 5 amphetamines in blood by LC-MS/MS and application to real cases. J Pharm Biomed Anal. 2016;129:441–449.
   PubMed Web of Science ®Google Scholar
• Dickson AJ, Vorce SP, Levine B, et al. Multiple-drug toxicity caused by the coadministration of 4-methylmethcathinone (mephedrone) and heroin. J Anal Toxicol. 2010;34(3):162–168.
   PubMed Web of Science ®Google Scholar
• Maskell PD, De Paoli G, Seneviratne C, et al. Mephedrone (4-methylmethcathinone)-related deaths. J Anal Toxicol. 2011;35(3):188–191.
   PubMed Web of Science ®Google Scholar
• Wood DM, Davies S, Puchnarewicz M, et al. Recreational use of mephedrone (4-methylmethcathinone, 4-MMC) with associated sympathomimetic toxicity. J Med Toxicol. 2010;6(3):327–330.
   PubMedGoogle Scholar
• Cosbey SH, Peters KL, Quinn A, et al. Mephedrone (methylmethcathinone) in toxicology casework: a Northern Ireland perspective. J Anal Toxicol. 2013;37(2):74–82.
   PubMed Web of Science ®Google Scholar
• Pedersen AJ, Reitzel LA, Johansen SS, Linnet K. In vitro metabolism studies on mephedrone and analysis of forensic cases. Drug Test Anal. 2013;5(6):430–438.
   PubMed Web of Science ®Google Scholar
• Loi B, Corkery JM, Claridge H, et al. Deaths of individuals aged 16-24 years in the UK after using mephedrone. Hum Psychopharmacol. 2015;30(4):225–232.
   PubMed Web of Science ®Google Scholar
• Busardò FP, Kyriakou C, Napoletano S, et al. Mephedrone related fatalities: a review. Eur Rev Med Pharmacol Sci. 2015;19(19):3777–3790.
   PubMed Web of Science ®Google Scholar
• Corkery JM, Schifano F, Ghodse AH. Mephedrone-related fatalities in the United Kingdom: contextual, clinical and practical issues. Pharmacology. 2012;17:355–380.
   Google Scholar
• Papaseit E, Olesti E, de la Torre R, et al. Mephedrone concentrations in cases of clinical intoxication. Curr Pharm Des. 2017;23(36):5511–5522.
   PubMed Web of Science ®Google Scholar
• Anzillotti L, Calò L, Banchini A, et al. Mephedrone and chemsex: a case report. Leg Med (Tokyo). 2020;42:101640.
   PubMed Web of Science ®Google Scholar
• Aromatario M, Bottoni E, Santoni M, et al. New "lethal highs": a case of a deadly cocktail of GHB and mephedrone. Forensic Sci Int. 2012;223(1-3):e38–e41.
   PubMed Web of Science ®Google Scholar
• Papaseit E, Moltó J, Muga R, et al. Clinical pharmacology of the synthetic cathinone mephedrone. Curr Top Behav Neurosci. 2017;32:313–331.
   PubMedGoogle Scholar
• Papaseit E, Pérez-Mañá C, Mateus JA, et al. Human pharmacology of mephedrone in comparison with MDMA. Neuropsychopharmacology. 2016;41(11):2704–2713.
   PubMed Web of Science ®Google Scholar
• Schifano F, Corkery J, Ghodse AH. Suspected and confirmed fatalities associated with mephedrone (4-methylmethcathinone, "meow meow") in the United Kingdom. J Clin Psychopharmacol. 2012;32(5):710–714.
   PubMed Web of Science ®Google Scholar
• Burch HJ, Clarke EJ, Hubbard AM, et al. Concentrations of drugs determined in blood samples collected from suspected drugged drivers in England and Wales. J Forensic Leg Med. 2013;20(4):278–289.
   PubMed Web of Science ®Google Scholar
• Olesti E, Pujadas M, Papaseit E, et al. GC-MS quantification method for mephedrone in plasma and urine: application to human pharmacokinetics. J Anal Toxicol. 2017;41(2):100–106.
   PubMed Web of Science ®Google Scholar
• de Sousa Fernandes Perna EB, Papaseit E, Pérez-Mañá C, et al. Neurocognitive performance following acute mephedrone administration, with and without alcohol. J Psychopharmacol. 2016;30(12):1305–1312.
   PubMed Web of Science ®Google Scholar
• Belhadj-Tahar H, Sadeg N. Methcathinone: a new postindustrial drug. Forensic Sci Int. 2005;153(1):99–101.
   PubMed Web of Science ®Google Scholar
• Wikström M, Thelander G, Nyström I, et al. Two fatal intoxications with the new designer drug methedrone (4-methoxymethcathinone). J Anal Toxicol. 2010;34(9):594–598.
   PubMed Web of Science ®Google Scholar
• Pearson JM, Hargraves TL, Hair LS, et al. Three fatal intoxications due to methylone. J Anal Toxicol. 2012;36(6):444–451.
   PubMed Web of Science ®Google Scholar
• Carbone PN, Carbone DL, Carstairs SD, et al. Sudden cardiac death associated with methylone use. Am J Forensic Med Pathol. 2013;34(1):26–28.
   PubMed Web of Science ®Google Scholar
• Nisbet LA, Wylie FM, Logan BK, et al. Gas chromatography-mass spectrometry method for the quantitative identification of 23 new psychoactive substances in blood and urine. J Anal Toxicol. 2019;43(5):346–352.
   PubMed Web of Science ®Google Scholar
• Knoy JL, Peterson BL, Couper FJ. Suspected impaired driving case involving α-pyrrolidinovalerophenone, methylone and ethylone. J Anal Toxicol. 2014;38(8):615–617.
   PubMed Web of Science ®Google Scholar
• Kovács K, Tóth AR, Kereszty EM. [A new designer drug: methylone related death]. Orv Hetil. 2012;153(7):271–276.
   PubMedGoogle Scholar
• McIntyre IM, Hamm CE, Aldridge L, et al. Acute methylone intoxication in an accidental drowning-a case report. Forensic Sci Int. 2013;231(1-3):e1–e3.
   PubMed Web of Science ®Google Scholar
• Barrios L, Grison-Hernando H, Boels D, et al. Death following ingestion of methylone. Int J Legal Med. 2016;130(2):381–385.
   PubMed Web of Science ®Google Scholar
• Shimomura ET, Briones AJ, Warren WS, et al. Case report of methylone, oxymorphone and ethanol in a fatality case with tissue distribution. J Anal Toxicol. 2016;40(7):543–545.
   PubMed Web of Science ®Google Scholar
• Bauer A, Schopfer J, Sachs H, et al. Fatality after intake of methylone, MDMA and amphetamine: a case report. Toxichem Krimtech. 2013;80:343–345.
   Google Scholar
• Jebadurai J, Schifano F, Deluca P. Recreational use of 1-(2-naphthyl)-2-(1-pyrrolidinyl)-1-pentanone hydrochloride (NRG-1), 6-(2-aminopropyl) benzofuran (benzofury/ 6-APB) and NRG-2 with review of available evidence-based literature. Hum Psychopharmacol. 2013;28(4):356–364.
   PubMed Web of Science ®Google Scholar
• Derungs A, Schietzel S, Meyer MR, et al. Sympathomimetic toxicity in a case of analytically confirmed recreational use of naphyrone (naphthylpyrovalerone). Clin Toxicol (Phila). 2011;49(7):691–693.
   PubMed Web of Science ®Google Scholar
• Kovács K, Kereszty É, Berkecz R, et al. Fatal intoxication of a regular drug user following N-ethyl-hexedrone and ADB-FUBINACA consumption. J Forensic Leg Med. 2019;65:92–100.
   PubMed Web of Science ®Google Scholar
• Mikołajczyk A, Adamowicz P, Tokarczyk B, et al. Determination of N-ethylhexedrone, a new cathinone derivative, in blood collected from drivers – analysis of three cases. Probl Forensic Sci. 2017;109:53–63.
   Google Scholar
• Richards-Waugh L, Bailey K, Clay D, et al. Deaths involving the recreational use of α-PVP (α-pyrrolidinopentiophenone). K16, 65th Proceedings of the American Academy of Forensic Sciences, 2013:p. 521–522.
   Google Scholar
• Sykutera M, Cychowska M, Bloch-Boguslawska E. A fatal case of pentedrone and α-pyrrolidinovalerophenone poisoning. J Anal Toxicol. 2015;39(4):324–329.
   PubMed Web of Science ®Google Scholar
• Rojek S, Korczyńska-Albert M, Kulikowska J, et al. New challenges in toxicology of new psychoactive substances exemplified by fatal cases after UR-144 and UR-144 with pentedrone administration determined by LC-ESI-MS-MS in blood samples. Arch Med Sadowej Kryminol. 2017;67(2):104–120.
   PubMedGoogle Scholar
• Margasińska-Olejak J, Wiechuła D, Majchrzak M, et al. [Fatal poisoning of pentedron – cases reports]. Przeglad Lekarski. 2016;73(9):675–677.
   PubMedGoogle Scholar
• WHO. Pentedrone Critical Review Report. Agenda item 4.6. Expert Committee on Drug Dependence. Thirty-eighth Meeting, Geneva, 14-18 November 2016.
   Google Scholar
• Mercieca G, Odoardi S, Cassar M, et al. Rapid and simple procedure for the determination of cathinones, amphetamine-like stimulants and other new psychoactive substances in blood and urine by GC-MS. J Pharm Biomed Anal. 2018;149:494–501.
   PubMed Web of Science ®Google Scholar
• Hasegawa K, Wurita A, Minakata K, et al. Identification and quantitation of a new cathinone designer drug PV9 in an "aroma liquid" product, antemortem whole blood and urine specimens, and a postmortem whole blood specimen in a fatal poisoning case. Forensic Toxicol. 2014;32(2):243–250.
   Web of Science ®Google Scholar
• Minakata K, Yamagishi I, Nozawa H, et al. Determination of new pyrrolidino cathinone derivatives. Forensic Toxicol. 2015;33(1):148–154.
   Web of Science ®Google Scholar
• Majchrzak M, Celiński R, Kowalska T, et al. Fatal case of poisoning with a new cathinone derivative: α-propylaminopentiophenone (N-PP). Forensic Toxicol. 2018;36(2):525–533.
   PubMed Web of Science ®Google Scholar
• Gil D. α-PVT – a “successor” to α-PVP, a new psychoactive substance in biological material. Case analysis. Probl Forensic Sci. 2016;106:496–501.
   Google Scholar
• Wurita A, Hasegawa K, Minakata K, et al. Postmortem distribution of α-pyrrolidinobutiophenone in body fluids and solid tissues of a human cadaver. Leg Med (Tokyo). 2014;16(5):241–246.
   PubMed Web of Science ®Google Scholar
• Franzén L, Bäckberg M, Beck O, et al. Acute intoxications involving α-pyrrolidinobutiophenone (α-PBP): results from the Swedish STRIDA Project. J Med Toxicol. 2018;14(4):265–271.
   PubMed Web of Science ®Google Scholar
• Pieprzyca E, Skowronek R, Korczyńska M, et al. A two fatal cases of poisoning involving new cathinone derivative PV8. Leg Med (Tokyo). 2018;33:42–47.
   PubMed Web of Science ®Google Scholar
• Hisatsune K, Zaitsu K, Kusano M, et al. Determination of newly encountered designer drugs α-php and acetylfentanyl in an acute intoxication case by LC/Q-TOFMS. 53rd TIAFT Meeting, Firenze, Italy, 2015.
   Google Scholar
• Fujita Y, Mita T, Usui K, et al. Toxicokinetics of the synthetic cathinone α-pyrrolidinohexanophenone. J Anal Toxicol. 2018;42(1):e1–e5.
   PubMed Web of Science ®Google Scholar
• Vignali C, Moretti M, Groppi A, et al. Distribution of the synthetic cathinone α-pyrrolidinohexiophenone in biological specimens. J Anal Toxicol. 2019;43(1):e1–e6.
   PubMed Web of Science ®Google Scholar
• WHO. Critical review report: alpha-PHP (α-pyrrolidinohexanophenone) or PV-7. Expert Committee on Drug Dependence. Forty-Second Meeting Geneva. 21–25 October 2019.
   Google Scholar
• Adamowicz P, Jurczyk A, Gil D, et al. A case of intoxication with a new cathinone derivative α-PiHP - a presentation of concentrations in biological specimens. Leg Med (Tokyo). 2020;42:101626.
   PubMed Web of Science ®Google Scholar
• Eiden C, Mathieu O, Cathala P, et al. Toxicity and death following recreational use of 2-pyrrolidino valerophenone. Clin Toxicol (Phila). 2013;51(9):899–903.
   PubMed Web of Science ®Google Scholar
• Saito T, Namera A, Osawa M, et al. SPME–GC–MS analysis of α-pyrrolidinovaleorophenone in blood in a fatal poisoning case. Forensic Toxicol. 2013;31(2):328–332.
   Web of Science ®Google Scholar
• Minakata K, Yamagishi I, Nozawa H, et al. MALDI-TOF mass spectrometric determination of four pyrrolidino cathinones in human blood. Forensic Toxicol. 2014;32(1):169–175.
   Web of Science ®Google Scholar
• Nagai H, Saka K, Nakajima M, et al. Sudden death after sustained restraint following self-administration of the designer drug α-pyrrolidinovalerophenone. Int J Cardiol. 2014;172(1):263–265.
   PubMed Web of Science ®Google Scholar
• Hasegawa K, Suzuki O, Wurita A, et al. Postmortem distribution of α-pyrrolidinovalerophenone and its metabolite in body fluids and solid tissues in a fatal poisoning case measured by LC-MS-MS with the standard addition method. Forensic Toxicol. 2014;32(2):225–234.
   Web of Science ®Google Scholar
• Wright TH, Harris C. Twenty-one cases involving alpha-pyrrolidinovalerophenone (α-PVP). J Anal Toxicol. 2016;40(5):396–402.
   PubMed Web of Science ®Google Scholar
• Kula K, Rojek S, Maciów-Glab M, et al. α-PVP in fatal cases. XXXIII Conference of Forensic Toxicologists, Poznań, Poland, 11–13 May 2016. Abstract Book 2016, 49–50.
   Google Scholar
• Umebachi R, Aoki H, Sugita M, et al. Clinical characteristics of α-pyrrolidinovalerophenone (α-PVP) poisoning. Clin Toxicol (Phila). 2016;54(7):563–567.
   PubMed Web of Science ®Google Scholar
• Quesada L, Gomila I, Yates C, et al. Elimination half-life of alpha-pyrrolidinovalerophenone in an acute non-fatal intoxication. Clin Toxicol (Phila). 2016;54(6):531–532.
   PubMed Web of Science ®Google Scholar
• Rojek S, Kula K, Maciow-Glab M, et al. New psychoactive substance α-PVP in a traffic accident case. Forensic Toxicol. 2016;34:403–410.
   PubMed Web of Science ®Google Scholar
• Beck O, Franzén L, Bäckberg M, et al. Toxicity evaluation of α-pyrrolidinovalerophenone (α-PVP): results from intoxication cases within the STRIDA project. Clin Toxicol (Phila). 2016;54(7):568–575.
   PubMed Web of Science ®Google Scholar
• Grapp M, Sauer C, Vidal C, et al. GC-MS analysis of the designer drug α-pyrrolidinovalerophenone and its metabolites in urine and blood in an acute poisoning case. Forensic Sci Int. 2016;259:e14–e19.
   PubMed Web of Science ®Google Scholar
• Potocka-Banaś B, Janus T, Majdanik S, et al. Fatal intoxication with α-PVP, a synthetic cathinone derivative. J Forensic Sci. 2017;62(2):553–556.
   PubMed Web of Science ®Google Scholar
• Shanks KG, Behonick GS, Terrell AR. Detection of alpha-PVP in postmortem blood casework by UPLC/MS/MS P12, Proceedings of the Society of Forensic Toxicologists 2013. Available from: http://soft-tox.org/files/meeting_abstracts/SOFT_2013_meeting_abstracts.pdf
   Google Scholar
• Adamowicz P. Blood concentrations of synthetic cannabinoids. Clin Toxicol (Phila). 2020;:1–6. DOI:10.1080/15563650.2020.1787429
   PubMed Web of Science ®Google Scholar
• Glicksberg L, Kerrigan S. Stability of synthetic cathinones in blood. J Anal Toxicol. 2017;41(9):711–719.
   PubMed Web of Science ®Google Scholar
• Adamowicz P, Malczyk A. Stability of synthetic cathinones in blood and urine. Forensic Sci Int. 2019;295:36–45.
   PubMed Web of Science ®Google Scholar